郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价[Lysalbinic acid--a new absorption enhancer for the buccal delivery of peptide drugs].

期刊:Ukrains'kyi biokhimichnyi zhurnal (1999 )发表年份:2005作者:P L Starokadomskiĭ; I Ia Dubeĭ

药效评价High-resolution FISH analysis.

期刊:Current protocols in human genetics发表年份:2005作者:Henry H Q Heng; Bradford Windle; Lap-Chee Tsui

药效评价Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist.

期刊:Bioorganic & medicinal chemistry letters发表年份:2005作者:Yutaka Nakajima; Hitoshi Hamashima; Ken-Ichi Washizuka; Yasuyo Tomishima; Hiroaki Ohtake; Emiko Imamura; Toshiko Miura; Hiroshi Kayakiri; Masayuki Kato

药效评价Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.

期刊:Autonomic & autacoid pharmacology发表年份:2005作者:S Siehler; C Nunn; G K H Zupanc; D Hoyer